Nanostring appoints dr. teresa foy to board of directors

Seattle--(business wire)--nanostring technologies, inc. (nasdaq: nstg), a leading provider of life science tools for discovery and translational research, today announced the appointment of dr. teresa (teri) foy to the board of directors, effective april 18, 2022. “i am honored to welcome dr. foy to the team. teri is a leader in immuno-oncology and cellular therapy, with decades of experience in pharmaceutical research,” said president and chief executive officer brad gray. “immunology and onco
NSTG Ratings Summary
NSTG Quant Ranking